Reliability of intravitreal nepafenac in rabbits

The purpose of this experiment was to investigate the possible toxic effects of Nepafenac, a nonsteroidal anti-inflammatory molecule, after its intravitreal application in various concentrations. Forty pigmented rabbits were randomly divided into 4 groups, each including 10 rabbits. The active ingre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ocular pharmacology and therapeutics 2015-02, Vol.31 (1), p.43-50
Hauptverfasser: Afrashi, Filiz, Hashas, Arzu Seyhan Karatepe, Shahbazov, Cahit, Arici, Mesut, Yikilmaz, Mehmet Salih, Deveci, Remziye, Karacali, Sabire, Sahar, Umut
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 50
container_issue 1
container_start_page 43
container_title Journal of ocular pharmacology and therapeutics
container_volume 31
creator Afrashi, Filiz
Hashas, Arzu Seyhan Karatepe
Shahbazov, Cahit
Arici, Mesut
Yikilmaz, Mehmet Salih
Deveci, Remziye
Karacali, Sabire
Sahar, Umut
description The purpose of this experiment was to investigate the possible toxic effects of Nepafenac, a nonsteroidal anti-inflammatory molecule, after its intravitreal application in various concentrations. Forty pigmented rabbits were randomly divided into 4 groups, each including 10 rabbits. The active ingredient Nepafenac was prepared to be applied in different doses, for intravitreal use. Under topical anesthesia, following pupil dilatation, 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac was applied intravitreally into the right eye. In each rabbit, the right eye was considered to be the study group. Saline was injected intravitreally into the left eye of each rabbit, and these eyes were considered to be the control group. Immediately after the injection and at the 1st, 4th, and 8th weeks, fundus examination by indirect ophthalmoscopy and intraocular pressure measurement were conducted. Furthermore, electroretinographic (ERG) recordings were taken at the 4th and 8th weeks. At the end of the 8th week, eyes of the surviving 26 rabbits were enucleated, and then animals were sacrificed. Following necessary fixation procedures, histopathological investigations were conducted by using a light and electron microscope. In the histological cross sections, differences between the eyes with injection and the control group were evaluated, and total retinal thickness, inner nuclear layer thickness, and outer nuclear layer thickness were measured. No pathology was found by clinical examination of either group. In the photopic and scotopic full-field ERG, conducted before the injection and in the 4th and 8th weeks after the injection, no statistically significant difference was determined between the study group and the control group. In the histological evaluation of the preparations, there were no statistically significant differences in the retina thickness of control and study groups. In the electron microscopic examinations, there were no toxicity findings in the eyes with injection. Our data show that intravitreal application of 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac active substance is nontoxic to the rabbit retina.
doi_str_mv 10.1089/jop.2014.0053
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1089_jop_2014_0053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>25285465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-777227d237ddbfef60ea7b65ece1e9288187c563315bbf63f9e997fa339118f23</originalsourceid><addsrcrecordid>eNo9j1tLw0AQhRdRbK0--ir5A6mzO93boxRvUBBEn5fdZBa2pEnYRKH_3oSqT3MYPg7nY-yWw5qDsff7rl8L4Js1gMQztuRS6lJrFOdTBgOlVgYX7GoY9gAcQfFLthBSGLlRcsngnZrkQ2rSeCy6WKR2zP47jZl8U7TU-0itr6Z3kX0IaRyu2UX0zUA3v3fFPp8eP7Yv5e7t-XX7sCsrYXGcFmghdC1Q13WIFBWQ10FJqoiTFcZwoyupELkMISqMlqzV0SNazk0UuGLlqbfK3TBkiq7P6eDz0XFws7mbzN1s7mbzib878f1XOFD9T_-p4g9yllPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reliability of intravitreal nepafenac in rabbits</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Afrashi, Filiz ; Hashas, Arzu Seyhan Karatepe ; Shahbazov, Cahit ; Arici, Mesut ; Yikilmaz, Mehmet Salih ; Deveci, Remziye ; Karacali, Sabire ; Sahar, Umut</creator><creatorcontrib>Afrashi, Filiz ; Hashas, Arzu Seyhan Karatepe ; Shahbazov, Cahit ; Arici, Mesut ; Yikilmaz, Mehmet Salih ; Deveci, Remziye ; Karacali, Sabire ; Sahar, Umut</creatorcontrib><description>The purpose of this experiment was to investigate the possible toxic effects of Nepafenac, a nonsteroidal anti-inflammatory molecule, after its intravitreal application in various concentrations. Forty pigmented rabbits were randomly divided into 4 groups, each including 10 rabbits. The active ingredient Nepafenac was prepared to be applied in different doses, for intravitreal use. Under topical anesthesia, following pupil dilatation, 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac was applied intravitreally into the right eye. In each rabbit, the right eye was considered to be the study group. Saline was injected intravitreally into the left eye of each rabbit, and these eyes were considered to be the control group. Immediately after the injection and at the 1st, 4th, and 8th weeks, fundus examination by indirect ophthalmoscopy and intraocular pressure measurement were conducted. Furthermore, electroretinographic (ERG) recordings were taken at the 4th and 8th weeks. At the end of the 8th week, eyes of the surviving 26 rabbits were enucleated, and then animals were sacrificed. Following necessary fixation procedures, histopathological investigations were conducted by using a light and electron microscope. In the histological cross sections, differences between the eyes with injection and the control group were evaluated, and total retinal thickness, inner nuclear layer thickness, and outer nuclear layer thickness were measured. No pathology was found by clinical examination of either group. In the photopic and scotopic full-field ERG, conducted before the injection and in the 4th and 8th weeks after the injection, no statistically significant difference was determined between the study group and the control group. In the histological evaluation of the preparations, there were no statistically significant differences in the retina thickness of control and study groups. In the electron microscopic examinations, there were no toxicity findings in the eyes with injection. Our data show that intravitreal application of 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac active substance is nontoxic to the rabbit retina.</description><identifier>ISSN: 1080-7683</identifier><identifier>EISSN: 1557-7732</identifier><identifier>DOI: 10.1089/jop.2014.0053</identifier><identifier>PMID: 25285465</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - toxicity ; Benzeneacetamides - administration &amp; dosage ; Benzeneacetamides - toxicity ; Dose-Response Relationship, Drug ; Electroretinography - methods ; Fundus Oculi ; Intraocular Pressure - drug effects ; Intravitreal Injections ; Ophthalmoscopy - methods ; Phenylacetates - administration &amp; dosage ; Phenylacetates - toxicity ; Rabbits ; Retina - cytology ; Retina - drug effects ; Retina - pathology</subject><ispartof>Journal of ocular pharmacology and therapeutics, 2015-02, Vol.31 (1), p.43-50</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c293t-777227d237ddbfef60ea7b65ece1e9288187c563315bbf63f9e997fa339118f23</citedby><cites>FETCH-LOGICAL-c293t-777227d237ddbfef60ea7b65ece1e9288187c563315bbf63f9e997fa339118f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25285465$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Afrashi, Filiz</creatorcontrib><creatorcontrib>Hashas, Arzu Seyhan Karatepe</creatorcontrib><creatorcontrib>Shahbazov, Cahit</creatorcontrib><creatorcontrib>Arici, Mesut</creatorcontrib><creatorcontrib>Yikilmaz, Mehmet Salih</creatorcontrib><creatorcontrib>Deveci, Remziye</creatorcontrib><creatorcontrib>Karacali, Sabire</creatorcontrib><creatorcontrib>Sahar, Umut</creatorcontrib><title>Reliability of intravitreal nepafenac in rabbits</title><title>Journal of ocular pharmacology and therapeutics</title><addtitle>J Ocul Pharmacol Ther</addtitle><description>The purpose of this experiment was to investigate the possible toxic effects of Nepafenac, a nonsteroidal anti-inflammatory molecule, after its intravitreal application in various concentrations. Forty pigmented rabbits were randomly divided into 4 groups, each including 10 rabbits. The active ingredient Nepafenac was prepared to be applied in different doses, for intravitreal use. Under topical anesthesia, following pupil dilatation, 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac was applied intravitreally into the right eye. In each rabbit, the right eye was considered to be the study group. Saline was injected intravitreally into the left eye of each rabbit, and these eyes were considered to be the control group. Immediately after the injection and at the 1st, 4th, and 8th weeks, fundus examination by indirect ophthalmoscopy and intraocular pressure measurement were conducted. Furthermore, electroretinographic (ERG) recordings were taken at the 4th and 8th weeks. At the end of the 8th week, eyes of the surviving 26 rabbits were enucleated, and then animals were sacrificed. Following necessary fixation procedures, histopathological investigations were conducted by using a light and electron microscope. In the histological cross sections, differences between the eyes with injection and the control group were evaluated, and total retinal thickness, inner nuclear layer thickness, and outer nuclear layer thickness were measured. No pathology was found by clinical examination of either group. In the photopic and scotopic full-field ERG, conducted before the injection and in the 4th and 8th weeks after the injection, no statistically significant difference was determined between the study group and the control group. In the histological evaluation of the preparations, there were no statistically significant differences in the retina thickness of control and study groups. In the electron microscopic examinations, there were no toxicity findings in the eyes with injection. Our data show that intravitreal application of 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac active substance is nontoxic to the rabbit retina.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - toxicity</subject><subject>Benzeneacetamides - administration &amp; dosage</subject><subject>Benzeneacetamides - toxicity</subject><subject>Dose-Response Relationship, Drug</subject><subject>Electroretinography - methods</subject><subject>Fundus Oculi</subject><subject>Intraocular Pressure - drug effects</subject><subject>Intravitreal Injections</subject><subject>Ophthalmoscopy - methods</subject><subject>Phenylacetates - administration &amp; dosage</subject><subject>Phenylacetates - toxicity</subject><subject>Rabbits</subject><subject>Retina - cytology</subject><subject>Retina - drug effects</subject><subject>Retina - pathology</subject><issn>1080-7683</issn><issn>1557-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j1tLw0AQhRdRbK0--ir5A6mzO93boxRvUBBEn5fdZBa2pEnYRKH_3oSqT3MYPg7nY-yWw5qDsff7rl8L4Js1gMQztuRS6lJrFOdTBgOlVgYX7GoY9gAcQfFLthBSGLlRcsngnZrkQ2rSeCy6WKR2zP47jZl8U7TU-0itr6Z3kX0IaRyu2UX0zUA3v3fFPp8eP7Yv5e7t-XX7sCsrYXGcFmghdC1Q13WIFBWQ10FJqoiTFcZwoyupELkMISqMlqzV0SNazk0UuGLlqbfK3TBkiq7P6eDz0XFws7mbzN1s7mbzib878f1XOFD9T_-p4g9yllPQ</recordid><startdate>201502</startdate><enddate>201502</enddate><creator>Afrashi, Filiz</creator><creator>Hashas, Arzu Seyhan Karatepe</creator><creator>Shahbazov, Cahit</creator><creator>Arici, Mesut</creator><creator>Yikilmaz, Mehmet Salih</creator><creator>Deveci, Remziye</creator><creator>Karacali, Sabire</creator><creator>Sahar, Umut</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201502</creationdate><title>Reliability of intravitreal nepafenac in rabbits</title><author>Afrashi, Filiz ; Hashas, Arzu Seyhan Karatepe ; Shahbazov, Cahit ; Arici, Mesut ; Yikilmaz, Mehmet Salih ; Deveci, Remziye ; Karacali, Sabire ; Sahar, Umut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-777227d237ddbfef60ea7b65ece1e9288187c563315bbf63f9e997fa339118f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - toxicity</topic><topic>Benzeneacetamides - administration &amp; dosage</topic><topic>Benzeneacetamides - toxicity</topic><topic>Dose-Response Relationship, Drug</topic><topic>Electroretinography - methods</topic><topic>Fundus Oculi</topic><topic>Intraocular Pressure - drug effects</topic><topic>Intravitreal Injections</topic><topic>Ophthalmoscopy - methods</topic><topic>Phenylacetates - administration &amp; dosage</topic><topic>Phenylacetates - toxicity</topic><topic>Rabbits</topic><topic>Retina - cytology</topic><topic>Retina - drug effects</topic><topic>Retina - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Afrashi, Filiz</creatorcontrib><creatorcontrib>Hashas, Arzu Seyhan Karatepe</creatorcontrib><creatorcontrib>Shahbazov, Cahit</creatorcontrib><creatorcontrib>Arici, Mesut</creatorcontrib><creatorcontrib>Yikilmaz, Mehmet Salih</creatorcontrib><creatorcontrib>Deveci, Remziye</creatorcontrib><creatorcontrib>Karacali, Sabire</creatorcontrib><creatorcontrib>Sahar, Umut</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of ocular pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Afrashi, Filiz</au><au>Hashas, Arzu Seyhan Karatepe</au><au>Shahbazov, Cahit</au><au>Arici, Mesut</au><au>Yikilmaz, Mehmet Salih</au><au>Deveci, Remziye</au><au>Karacali, Sabire</au><au>Sahar, Umut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reliability of intravitreal nepafenac in rabbits</atitle><jtitle>Journal of ocular pharmacology and therapeutics</jtitle><addtitle>J Ocul Pharmacol Ther</addtitle><date>2015-02</date><risdate>2015</risdate><volume>31</volume><issue>1</issue><spage>43</spage><epage>50</epage><pages>43-50</pages><issn>1080-7683</issn><eissn>1557-7732</eissn><abstract>The purpose of this experiment was to investigate the possible toxic effects of Nepafenac, a nonsteroidal anti-inflammatory molecule, after its intravitreal application in various concentrations. Forty pigmented rabbits were randomly divided into 4 groups, each including 10 rabbits. The active ingredient Nepafenac was prepared to be applied in different doses, for intravitreal use. Under topical anesthesia, following pupil dilatation, 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac was applied intravitreally into the right eye. In each rabbit, the right eye was considered to be the study group. Saline was injected intravitreally into the left eye of each rabbit, and these eyes were considered to be the control group. Immediately after the injection and at the 1st, 4th, and 8th weeks, fundus examination by indirect ophthalmoscopy and intraocular pressure measurement were conducted. Furthermore, electroretinographic (ERG) recordings were taken at the 4th and 8th weeks. At the end of the 8th week, eyes of the surviving 26 rabbits were enucleated, and then animals were sacrificed. Following necessary fixation procedures, histopathological investigations were conducted by using a light and electron microscope. In the histological cross sections, differences between the eyes with injection and the control group were evaluated, and total retinal thickness, inner nuclear layer thickness, and outer nuclear layer thickness were measured. No pathology was found by clinical examination of either group. In the photopic and scotopic full-field ERG, conducted before the injection and in the 4th and 8th weeks after the injection, no statistically significant difference was determined between the study group and the control group. In the histological evaluation of the preparations, there were no statistically significant differences in the retina thickness of control and study groups. In the electron microscopic examinations, there were no toxicity findings in the eyes with injection. Our data show that intravitreal application of 0.3, 0.5, 0.75, and 1.5 mg doses of Nepafenac active substance is nontoxic to the rabbit retina.</abstract><cop>United States</cop><pmid>25285465</pmid><doi>10.1089/jop.2014.0053</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1080-7683
ispartof Journal of ocular pharmacology and therapeutics, 2015-02, Vol.31 (1), p.43-50
issn 1080-7683
1557-7732
language eng
recordid cdi_crossref_primary_10_1089_jop_2014_0053
source MEDLINE; Alma/SFX Local Collection
subjects Animals
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - toxicity
Benzeneacetamides - administration & dosage
Benzeneacetamides - toxicity
Dose-Response Relationship, Drug
Electroretinography - methods
Fundus Oculi
Intraocular Pressure - drug effects
Intravitreal Injections
Ophthalmoscopy - methods
Phenylacetates - administration & dosage
Phenylacetates - toxicity
Rabbits
Retina - cytology
Retina - drug effects
Retina - pathology
title Reliability of intravitreal nepafenac in rabbits
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A22%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reliability%20of%20intravitreal%20nepafenac%20in%20rabbits&rft.jtitle=Journal%20of%20ocular%20pharmacology%20and%20therapeutics&rft.au=Afrashi,%20Filiz&rft.date=2015-02&rft.volume=31&rft.issue=1&rft.spage=43&rft.epage=50&rft.pages=43-50&rft.issn=1080-7683&rft.eissn=1557-7732&rft_id=info:doi/10.1089/jop.2014.0053&rft_dat=%3Cpubmed_cross%3E25285465%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25285465&rfr_iscdi=true